[Clinical experiences in tumor-oriented anti-cancer drugs].
Ohsawa
N
N
D000284:Administration, Oral; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002699:Chlorambucil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004961:Estramustine / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011238:Prednimustine / Q000627:therapeutic use; D011956:Receptors, Cell Surface
D000911:Antibodies, Monoclonal; D011956:Receptors, Cell Surface; D002699:Chlorambucil; D004961:Estramustine; D004958:Estradiol; C036613:bestrabucil; D011238:Prednimustine